Directorio de personas
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Grado: Doctor/a

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Publicaciones

  • Alfon, J.; Erazo, T.; Perez-Montoyo, H.; Domenech, C.; Puig, T.; Segura, M. F.; Matias-Guiu, X.; Rodon, J.; Nadal, E.; Oaknin, A.; Gil, M.; Vidal, L.; Gascon, P.; Lizcano, J. M.

    ABTL0812 AN AUTOPHAGY-ANTICANCER DRUG IN PHASE II CLINICAL TRIALS THAT INHIBITS PI3K/AKT/MTOR PATHWAY BY INDUCING TRIB3 EXPRESSION

    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY 121 30-30. .

  • Alsina-Sanchis, E; Figueras, A; Lahiguera, A; Gil-Martin, M; Pardo, B; Piulats, JM; Marti, L; Ponce, J; Matias-Guiu, X; Vidal, A; Villanueva, A; Viñals F

    TGF Controls Ovarian Cancer Cell Proliferation

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 18 -. .

    [doi:10.3390/ijms18081658]

  • Eritja, N; Felip, I; Dosil, MA; Vigezzi, L; Mirantes, C; Yeramian, A; Navaridas, R; Santacana, M; Llobet-Navas, D; Yoshimura, A; Nomura, M; Encinas, M; Matias-Guiu, X; Dolcet, X

    A Smad3-PTEN regulatory loop controls proliferation and apoptotic responses to TGF-beta in mouse endometrium

    CELL DEATH AND DIFFERENTIATION 24 1443-1458. .

    [doi:10.1038/cdd.2017.73]

  • Curras-Freixes, M; Piñeiro-Yañez E; Montero-Conde, C; Apellaniz-Ruiz, M; Calsina, B; Mancikova, V; Remacha, L; Richter, S; Ercolino, T; Rogowski-Lehmann, N; Deutschbein, T; Calatayud, M; Guadalix, S; Alvarez-Escola, C; Lamas, C; Aller, J; Sastre-Marcos, J; Lazaro, C; Galofre, JC; Patiño-García A; Meoro-Aviles, A; Balmaña-Gelpi J; De Miguel-Novoa, P; Balbin, M; Matias-Guiu, X; Leton, R; Inglada-Perez, L; Torres-Perez, R; Roldan-Romero, JM; Rodriguez-Antona, C; Fliedner SMJ; Opocher, G; Pacak, K; Korpershoek, E; de Krijger, RR; Vroonen, L; Mannelli, M; Fassnacht, M; Beuschlein, F; Eisenhofer, G; Cascon, A; Al-Shahrour, F; Robledo, M

    A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics

    Journal Of Molecular Diagnostics 19 575-588. .

    [doi:10.1016/j.jmoldx.2017.04.009]

  • Barcelo, C; Maiques, O; Panosa, A; Pijuan, J; Orgaz, JL; Vilella, R; Fabra, A; Puig, S; Sanz-Moreno, V; Matias-Guiu, X; Herreros, J; Canti, C; Macia, A; Marti, RM

    T-type calcium channel blockers reduce migration/invasion in BRAFV600E melanoma cells by inhibiting autophagy

    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 31 66-66. .

  • Maiques, O; Moreno, S; Romero, M; Santacana, M; Gomez, I; Velasco, A; Macia, A; Barcelo, C; Boix, R; Valls, J; Gatius, S; Canti, C; Matias-Guiu, X; Soria, X; Marti, RM

    Differential immunoexpression of senescence markers, tumor suppressor genes, BRAF-V600E and T-type calcium channels in acquired nevi according to their histopathological and dermoscopic classification

    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 31 65-65. .

  • Dosil, MA; Mirantes, C; Eritja, N; Felip, I; Navaridas, R; Gatius, S; Santacana, M; Colàs E; Moiola, C; Schoenenberger, JA; Encinas, M; Gari, E; Matias-Guiu, X; Dolcet, X

    Palbociclib has antitumour effects on Pten-deficient endometrial neoplasias

    JOURNAL OF PATHOLOGY 242 152-164. .

    [doi:10.1002/path.4896]

  • Mateo, F; Arenas, EJ; Aguilar, H; Serra-Musach, J; de Garibay, GR; Boni, J; Maicas, M; Du, S; Iorio, F; Herranz-Ors, C; Islam, A; Prado, X; Llorente, A; Petit, A; Vidal, A; Catala, I; Soler, T; Venturas, G; Rojo-Sebastian, A; Serra, H; Cuadras, D; Blanco, I; Lozano, J; Canals, F; Sieuwerts, AM; de Weerd, V; Look, MP; Puertas, S; Garcia, N; Perkins, AS; Bonifaci, N; Skowron, M; Gomez-Baldo, L; Hernandez, V; Martinez-Aranda, A; Martinez-Iniesta, M; Serrat, X; Ceron, J; Brunet, J; Barretina, MP; Gil, M; Falo, C; Fernandez, A; Morilla, I; Pernas, S; Pla, MJ; Andreu, X; Segui, MA; Ballester, R; Castella, E; Nellist, M; Morales, S; Valls, J; Velasco, A; Matias-Guiu, X; Figueras, A; Sanchez-Mut, JV; Sanchez-Cespedes, M; Cordero, A; Gomez-Miragaya, J; Palomero, L; Gomez, A; Gajewski, TF; Cohen, EEW; Jesiotr, M; Bodnar, L; Quintela-Fandino, M; Lopez-Bigas, N; Valdes-Mas, R; Puente, XS; Viñals F; Casanovas, O; Graupera, M; Hernandez-Losa, J; Ramón Y Cajal S; Garcia-Alonso, L; Saez-Rodriguez, J; Esteller, M; Sierra, A; Martin-Martin, N; Matheu, A; Carracedo, A; Gonzalez-Suarez, E; Nanjundan, M; Cortes, J; Lazaro, C; Odero, MD; Martens, JWM; Moreno-Bueno, G; Barcellos-Hoff, MH; Villanueva, A; Gomis, RR; Pujana, MA

    Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition

    ONCOGENE 36 2737-2749. .

    [doi:10.1038/onc.2016.427]

  • Maiques, O; Macia, A; Moreno, S; Barcelo, C; Santacana, M; Vea, A; Herreros, J; Gatius, S; Ortega, E; Valls, J; Chen, BJ; Llobet-Navas, D; Matias-Guiu, X; Canti, C; Marti, RM

    Immunohistochemical analysis of T-type calcium channels in acquired melanocytic naevi and melanoma

    BRITISH JOURNAL OF DERMATOLOGY 176 1247-1258. .

    [doi:10.1111/bjd.15121]

  • Garcia-Sanz, P; Triviño JC; Mota, A; Perez Lopez, M; Colas, E; Rojo-Sebastian, A; Garcia, A; Gatius, S; Ruiz, M; Prat, J; Lopez-Lopez, R; Abal, M; Gil-Moreno, A; Reventos, J; Matias-Guiu, X; Moreno-Bueno, G

    Chromatin remodelling and DNA repair genes are frequently mutated in endometrioid endometrial carcinoma

    INTERNATIONAL JOURNAL OF CANCER 140 1551-1563. .

    [doi:10.1002/ijc.30573]

  • Piulats, JM; Guerra, E; Gil-Martin, M; Roman-Canal, B; Gatius, S; Sanz-Pamplona, R; Velasco, A; Vidal, A; Matias-Guiu, X

    Molecular approaches for classifying endometrial carcinoma

    GYNECOLOGIC ONCOLOGY 145 200-207. .

    [doi:10.1016/j.ygyno.2016.12.015]

  • Mancikova, V; Montero-Conde, C; Perales-Paton, J; Fernandez, A; Santacana, M; Jodkowska, K; Inglada-Perez, L; Castelblanco, E; Borrego, S; Encinas, M; Matias-Guiu, X; Fraga, M; Robledo, M

    Multilayer OMIC Data in Medullary Thyroid Carcinoma Identifies the STAT3 Pathway as a Potential Therapeutic Target in RETM918T Tumors

    CLINICAL CANCER RESEARCH 23 1334-1345. .

    [doi:10.1158/1078-0432.CCR-16-0947]

Proyectos

  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU
  • Genomic approach for individualizing endometrial cancer diagnosis, prognosis and treatment